Kelly Paul Edward

Average Profitability
87.38%
Insider Buys Quantity
6
Insider Buys Sum
$621,620.00
Insider Sells Quantity
11
Insider Sells Sum
$1.15M

Insider Activity of Kelly Paul Edward

According to the SEC Form 4 filings, Kelly Paul Edward, being in a position of

  1. director at Relmada Therapeutics, Inc.,
    оver the last 12 months, has bought 25000 shares for $64,750, and sold 0 shares,
    over all time since 2015-12-14, has bought 450000 shares for $621,620, and sold 34700 shares for $1.15M.

The largest purchase of all time was on 2018-10-12 and amounted to 300000 shares of Relmada Therapeutics, Inc. for $270,000.

The largest sale of all time was on 2022-04-04 and amounted to 10000 shares of Relmada Therapeutics, Inc. for $300,395.

Biography of Kelly Paul Edward

No biography is available at this moment.

2024-09-09PurchaseRelmada Therapeutics, Inc.
RLMD
director
25,000
0.0769%
$2.59$64,750+21.86%
2022-04-04SaleRelmada Therapeutics, Inc.
RLMD
10,000
0.0335%
$30.04$300,395-39.79%
2021-03-09SaleRelmada Therapeutics, Inc.
RLMD
director
5,000
0.031%
$35.71$178,551-27.03%
2021-02-24SaleRelmada Therapeutics, Inc.
RLMD
director
5,000
0.03%
$34.19$170,933-24.9%
2021-02-09SaleRelmada Therapeutics, Inc.
RLMD
director
2,069
0.0126%
$35.28$73,005-24.84%
2021-02-08SaleRelmada Therapeutics, Inc.
RLMD
director
1,500
0.0091%
$35.04$52,560-24.46%
2021-02-02SaleRelmada Therapeutics, Inc.
RLMD
director
2,315
0.014%
$35.04$81,118-23.54%
2021-02-01SaleRelmada Therapeutics, Inc.
RLMD
director
31
0.0002%
$35.00$1,085-23.33%
2021-01-27SaleRelmada Therapeutics, Inc.
RLMD
director
5,000
0.0311%
$32.46$162,323-13.04%
2021-01-26SaleRelmada Therapeutics, Inc.
RLMD
director
685
0.0042%
$35.16$24,085-20.02%
2021-01-25SaleRelmada Therapeutics, Inc.
RLMD
director
1,300
0.0078%
$35.27$45,851-19.32%
2021-01-22SaleRelmada Therapeutics, Inc.
RLMD
director
1,800
0.0108%
$35.43$63,774-19%
2019-10-18PurchaseRelmada Therapeutics, Inc.
RLMD
director
5,000
0.0495%
$19.14$95,685+97.07%
2019-05-14PurchaseRelmada Therapeutics, Inc.
RLMD
director
100,000
0.3282%
$1.50$150,000+262.57%
2018-12-11PurchaseRelmada Therapeutics, Inc.
RLMD
director
10,000
0.0385%
$1.21$12,130+58.94%
2018-10-12PurchaseRelmada Therapeutics, Inc.
RLMD
director
300,000
0.9594%
$0.90$270,000+63.64%
2015-12-14PurchaseRelmada Therapeutics, Inc.
RLMD
director
10,000
0.0848%
$2.91$29,055-45.33%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.